Catalyst Wire Dossier Catalyst Wire Dossier

Vegzelma

bevacizumab · Celltrion Healthcare Hungary Kft.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Vegzelma, covering 2022-09-27 to 2026-01-28. Get the full timeline:

Most recent: EMA Authorised: Vegzelma (bevacizumab) — Celltrion Healthcare Hungary Kft.

See pricing